It did not administer Epithalon to living participants, measure whole-body ageing or examine lifespan
Clinical trial data shows that burping rates vary by drug and dose: Ozempic injection (semaglutide): Burping reported in 3% of patients at the 0.5 mg dose and 1% of patients at the 1 mg dose Wegovy injection (semaglutide): Burping reported in 7% of adults at the 2.4 mg dose Mounjaro and Zepbound (tirzepatide): Burping reported in 25% of patients across doses (Source: Drugs.com) These numbers likely underestimate real-world prevalence, as sulfur burps are often underreported in clinical trials or described under broader terms like belching or eructation. Some patients avoid mentioning it to their doctors out of embarrassment, as well
Specifically, these substances are secretagogues that enhance pituitary GH activity so as to sustain or increase lean body mass, while decreasing total and visceral body fat
The darker pigmentation can offer some UV protection, helping reduce sunburn risk
Despite the identification of many potential targets of antioxidant therapy, and abundant pre-clinical data, few antioxidant agents have undergone formal trials to assess clinical benefit in COPD